The US presidential election and the latest interest rate decisions from the US Federal Reserve and the Bank of England are likely to dominate market focus in the coming week, but there are also a number of major companies still due to report.
Investors will be looking to the latest report from Warren Buffett's firm Berkshire Hathaway (BRK-B), to garner any insights on markets from the "oracle of Omaha".
Billionaire Warren Buffett's firm Berkshire Hathaway kicks off the week's earnings releases on Saturday.
AJ Bell's Russ Mould, Danni Hewson and Dan Coatsworth point out that Berkshire Hathaway has actually been whittling down its exposure to stocks and US government bonds, known as Treasuries, and adding to its cash pile.
"Granted, some of that cash pile comes from the profits and operations of the industrial holdings, including its insurance businesses such as GEICO, the BSNF railroad, utilities and gas pipelines, industrial units such as Lubrizol and Precision Castparts and consumer-facing companies such as Duracell, See’s Candy and Borsheim’s jewellers," they said. "Yet a good portion of the increase has come from asset sales."
They noted that the Berkshire Hathaway's cash pile stood at a record $272bn (£208bn) at the end of June and regulatory filings indicate had sold some more stocks since, notably some of its bank holdings.
"Whether investors wish to interpret this as Buffett following his own mantra of being fearful when others are greedy (and greedy when others are fearful) will be a matter of taste, but acolytes and Berkshire shareholders may look upon this as a hint from the legendary investors that US equities have started to get more than a little overheated," they said.
US indices, including the main S&P 500 and the tech-focused Nasdaq (^IXIC), have been trading near all-time highs. However, earnings releases from Meta (META) and Microsoft (MSFT) sparked concern among investors about growing AI costs and the prospects for Big Tech more broadly, which weighed on markets.
In the coming week, the focus for markets is set to shift to the US presidential election on Tuesday and the US Federal Reserve's latest interest rate decision on Thursday.
A statement from Berkshire Hathaway last week clarified Buffett's public stance ahead of the election, saying that he "does not currently and will not prospectively endorse investment products or endorse and support political candidates".
In terms of Berkshire Hathaway's company performance, total revenue grew to $93.7bn in the second quarter, up from $92.5bn for the same period last year. However, net earnings fell to $30.5bn, from $36.2bn in Q2 2023. One of the major pieces of news to come from the results, was that Berkshire Hathaway had cuts its holdings in Apple (AAPL) by nearly 50%.
Shares in Super Micro Computer plunged after it was revealed that Ernst & Young (EY) had resigned as the server maker's auditor.
In a resignation letter, EY said: “We are resigning due to information that has recently come to our attention which has led us to no longer be able to rely on management's and the Audit Committee’s representations and to be unwilling to be associated with the financial statements prepared by management, and after concluding we can no longer provide the Audit Services in accordance with applicable law or professional obligations.”
Super Micro said in a filing that it "disagrees" with EY's decision and is "working diligently to select new auditors".
Read more: What the budget means for UK interest rates
This latest news comes after short seller firm Hindenburg Research released a report in August, in which "accounting manipulation" at Super Micro.
The US Department of Justice then reportedly launched an investigation into the firm.
Shares also fell sharply after Super Micro released fourth quarter results in August that missed both on profit and revenue expectations. Revenue came in at $5.31bn, slightly below estimates of $5.32bn. Meanwhile, earnings per share of $6.25, fell short of the $8.25 analysts had anticipated.
Looking ahead to the first quarter, Super Micro said expected to report net sales of $6bn to $7bn and net income per diluted share of $5.97 to $7.66.
For the 2025 fiscal year, the company said it expects to post net sale of $26bn to $30bn.
The maker of popular weight-loss drugs Ozempic and Wegovy, Novo Nordisk is facing rising competition in this space.
Eli Lilly (LLY) has said that it plans to advertise its drug, Zepbound, for the first time next month.
Novo Nordisk, once Europe's most valuable company, missed second quarter revenue estimates, which came in at $3.8bn versus forecasts of $4.1bn.
The company's sales of Wegovy came in weaker than expected, at 21bn Danish krone (£2.4bn).
Read more: Gold surges on Diwali day after biggest buying spree of the year
Novo Nordisk lowered its operating profit outlook growth for the year to between 20% and 28%, from a previous forecast of 22% to 30%. However, it raised its sales growth outlook to between 22% and 28%, from 19% and 27%.
CFO Karsten Munk Knudsen told Yahoo Finance: "Right now, demand is greater than supply for Wegovy and overall for the obesity market given the significant unmet need. We are scaling Wegovy as we speak already, significantly."
Following shortages, both Wegovy and Ozempic appeared as available on the US Food and Drug Administration's website on Wednesday.
In addition, Novo Nordisk announced results from the first part an ongoing trial on Friday, that Wegovy had demonstrated "superior improvement" in liver fibrosis.
More than £1bn was wiped off housebuilder Vistry's market valuation in early October, on the back of the company issuing a profit warning after it after it discovered costs in one division of its business had been understated.
Vistry said it had discovered that cost projections to complete nine of its 46 developments in its south division had been "understated" by around 10% of the total build costs.
As a result, the housebuilder estimated a "one-off impact" for revising development cost assumptions and now expected adjusted profits before tax for the 2024 fiscal year to be around £80m lower than previous forecast, at £350m. Vistry then expected adjusted pre-tax profits to be around £30m lower in 2025 and £5m down in 2026.
"We believe the issues are confined to the South Division and changes to the management team in the division are underway," Vistry said. "We are commencing an independent review to fully ascertain the causes."
Read more: UK bond market in turmoil as budget changes calculus of interest rates
Despite the impact of this discovery, Vistry said it continued to expect to deliver more than 18,000 units in total completions in its 2024 full-year.
The sharp fall in shares marked a reverse in for marked a reverse in fortunes for the stock which had become a favourite in the housebuilding sector more recently, particularly on the back of Labour's landslide general election victory in July.
Vistry announced in September last year that was pivoting its business to a partnerships model, continuing its focus on affordable housing, meaning it looked set to benefit from housebuilding policies and planning reforms.
In its half-year results, the company also posted 11% growth in revenues to £1.97bn and a 10% increase in operating profits at £227m.
Other housebuilders due to report next week include Persimmon (PSN.L) and Taylor Wimpey (TW.L).
Retailer Marks & Spencer posted a 41% jump in group profit before tax to £672.5m its in full-year results, released in May.
The high street favourite also reported a 9% increase in group revenue to £13bn, as it updated on progress on its "reshaping" strategy.
Highlights in performance included its 10% growth in market share in clothing and home, as well as nearly 7% volume growth in food.
Aarin Chiekrie, equity analyst at Hargreaves Lansdown, said: “Marks & Spencer has done a great job at breathing new life into the business over the past couple of years.
Read more: BP shares dip after announcing weakest profits in nearly four years
"Its food and clothing propositions have been sharpened, helping the group steal market share away from its competitors. Operations have also been streamlined, improving both profitability and the balance sheet enough to restore dividend payments last year."
The company announced a dividend of 3p per share for the 2023/24 fiscal year.
"Analysts expect to see this upward trajectory continue when results are announced next week," said Chiekrie.
M&S did not offer specific guidance in its outlook for this fiscal year, besides to say that the company was confident it could make further progress on delivering volume growth, market share and free cash flow.
Chiekrie said that markets have forecast first-half revenue to grow around 5% to £6.4bn, "which looks achievable".
"An update on M&S’s joint venture with Ocado will be of interest after relations were said to be souring and losses widening, so some better news on this front would be viewed favourably," he added.
Monday 4 November
Ryanair (RYA.IR)
Vertex (VRTX)
Palantir (PLTR)
Zoetis (ZTS)
Constellation Energy (CEG)
NXP Semiconductor (NXPI)
AIG (AIG)
Illumina (ILMN)
BioNTech (BNTX)
Fox (FOX)
Loews (L)
Yum! China (YUMC)
New York Times (NYT)
Lattice Semiconductor (LSCC)
Tuesday 5 November
Kingspan (KRX.IR)
ASOS (ASC.L)
Associated British Foods (ABF.L)
IWG (IWG.L)
Weir Group (WEIR.L)
Smiths News (SNWS.AQ)
TI Fluid Systems (TIFS.L)
Nintendo (NTDOF)
Aramco (2222.SR)
Coca-Cola Europacific (CCEP.L)
Coloplast (COLO.VI)
Bayer (BAYN.DE)
?rsted (DNNGY)
Uniper (UN0.DU)
Vestas Wind Systems (VWS.CO)
AIB (AIBG.L)
Fresenius Medical Care (FME.HM)
Finecobank (FNBKY)
Zalando (ZAL.F)
Hugo Boss (BOSSD.XC)
Ferrari (RACE)
Thomson Reuters (TRI.TO)
Marathon Petroleum (0JYA.L)
Cummins (CMI)
Microchip (MCP.BE)
Wednesday 6 November
Beazley (BEZ.L)
Dominos (0A7E.L)
Lancashire Holdings (LRE.L)
OSB Group (OSB.L)
Persimmon (PSN.L)
TBC Bank Group (TBCG.L)
Toyota Motor (0LG5.L)
Honda Motor (7267.T)
Kikkoman (KIKOY)
ENEL (0TGA.L)
Unicredit (UCG.MI)
Siemens Healthineers (0PMJ.L)
BMW (BMW.DE)
Henkel (0IZC.IL)
Ahold Delhaize (AD.AS)
Commerzbank (CBK.F)
Fresenius (0OO9.IL)
Pandora (PNDZF)
Puma (PMMAF)
Qualcomm (QCOM)
ARM (ARM)
Gilead Sciences (GILD)
CVS Health (0HRS.L)
Take-Two Interactive (0LCX.L)
Zillow Group (Z.MX)
Lyft (LYFT)
Thursday 7 November
National Grid (NG.L)
Auto Trader (AUTO.L)
IMI (IMI.L)
Howden Joinery (HWDN.L)
Derwent London (DLN.L)
Wood Group (WG.L)
Tate & Lyle (TATE.L)
Burford Capital (BUR.L)
Taylor Wimpey (TW.L)
Hiscox (HSX.L)
Hikma Pharmaceuticals (HIK.L)
ITV (ITV.L)
Nippon Steel (5401.T)
Nikon (7731.T)
Rohm (6963.T)
MunichRe (MUV2.DE)
Daimler Truck (DTG.DE)
Amadeus IT (AMS.MC)
Legrand (LR.PA)
Rheinmetall (RHM.DE)
ArcelorMittal (MT.AS)
Pirelli (PIRC.MI)
Brembo (BRE.MI)
Airbnb (ABNB)
CRH (CRH)
Block (SQ)
Hershey (HSY)
Rockwell (ROK)
Halliburton (HAL)
Pinterest (PINS)
Liberty Broadband (LBRDK)
Tapestry (TPR)
Rivian Automotive (RIVN)
Friday 8 November
Rightmove (RMV.L)
Sony (6758.T)
Olympus (7733.T)
Suzuki Motor (7269.T)
SMIC (0981.HK)
Singapore Airlines (C6L.SI)
Paramount Global (PARA)
You can read Yahoo Finance's full calendar here.
Download the Yahoo Finance app, available for Apple and Android.